These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36199420)

  • 21. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting.
    Chaudhary R; Agarwal N
    Asian J Transfus Sci; 2011 Jul; 5(2):157-9. PubMed ID: 21897596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relative utility of the autologous control and the antiglobulin test phase of the crossmatch.
    Perkins JT; Arruza M; Fong K; Sosler SD; Saporito C
    Transfusion; 1990; 30(6):503-7. PubMed ID: 2378021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of irregular red cell antibody in healthy blood donors attending a tertiary care hospital in North India.
    Makroo RN; Rajput S; Agarwal S; Chowdhry M; Prakash B; Karna P
    Asian J Transfus Sci; 2018; 12(1):17-20. PubMed ID: 29563670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A newly recognized blood group in domestic shorthair cats: the Mik red cell antigen.
    Weinstein NM; Blais MC; Harris K; Oakley DA; Aronson LR; Giger U
    J Vet Intern Med; 2007; 21(2):287-92. PubMed ID: 17427390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type and screen policy: is there any compromise on blood safety?
    Agrawal A
    Transfus Apher Sci; 2014 Apr; 50(2):271-3. PubMed ID: 24472664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythrocyte Alloimmunization and Autoimmunization among Blood Donors and Recipients visiting a Tertiary Care Hospital.
    Kaur D; Bains L; Kandwal M; Parmar I
    J Clin Diagn Res; 2017 Mar; 11(3):EC12-EC15. PubMed ID: 28511387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood type and screen for crossmatch].
    Taniwaki K
    Rinsho Byori; 1989 Jul; 37(7):745-9. PubMed ID: 2607645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant.
    López A; de la Rubia J; Arriaga F; Jiménez C; Sanz GF; Carpio N; Marty ML
    Transfusion; 1998 Mar; 38(3):247-51. PubMed ID: 9563404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A proposal for compatibility testing incorporating the manual hexadimethrine bromide (Polybrene) test.
    Steane EA; Steane SM; Montgomery SR; Pearson JR
    Transfusion; 1985; 25(6):540-4. PubMed ID: 4071598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of IgG anti-A/B must be essential for safe transfusion support in patients undergoing ABO incompatible allogeneic HSCT.
    Liu F; Li G; Mao X; Hu L
    Transfus Apher Sci; 2011 Apr; 44(2):123-7. PubMed ID: 21320800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of clinically significant antibodies in patients undergoing elective surgery in a Nigerian teaching hospital: A case for the type and screen method.
    Obi EI; Pughikumo OC; Korubo KI; Ejele AO
    Niger J Clin Pract; 2020 Feb; 23(2):138-146. PubMed ID: 32031086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted?
    Judd WJ; Fullen DR; Steiner EA; Davenport RD; Knafl PC
    Transfusion; 1999 Mar; 39(3):295-9. PubMed ID: 10204593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of micro column technology with conventional tube methods for antibody detection.
    Garg S; Saini N; Bedi RK; Basu S
    J Lab Physicians; 2017; 9(2):95-99. PubMed ID: 28367023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canine Dal blood type: A red cell antigen lacking in some Dalmatians.
    Blais MC; Berman L; Oakley DA; Giger U
    J Vet Intern Med; 2007; 21(2):281-6. PubMed ID: 17427389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of type and screen versus crossmatch in cardiovascular surgery patients: A comparative study.
    Pokhrel A; Jain A; Marwaha N; Singh RS
    Asian J Transfus Sci; 2022; 16(1):1-6. PubMed ID: 36199399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited.
    Judd WJ; Barnes BA; Steiner EA; Oberman HA; Averill DB; Butch SH
    Transfusion; 1986; 26(3):220-4. PubMed ID: 3705135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advantages of type and screen policy: Perspective from a developing country!
    Aggarwal G; Tiwari AK; Arora D; Dara RC; Acharya DP; Bhardwaj G; Sharma J
    Asian J Transfus Sci; 2018; 12(1):42-45. PubMed ID: 29563674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. North American pretransfusion testing practices, 2001-2004: results from the College of American Pathologists Interlaboratory Comparison Program survey data, 2001-2004.
    Shulman IA; Maffei LM; Downes KA
    Arch Pathol Lab Med; 2005 Aug; 129(8):984-9. PubMed ID: 16048410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization.
    Dinardo CL; Bonifácio SL; Mendrone A
    Immunohematology; 2014; 30(1):1-5. PubMed ID: 25238242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfusion Blood Bank (Recipient) Testing.
    Alquist CR; Helander L
    Clin Lab Med; 2021 Dec; 41(4):599-610. PubMed ID: 34689967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.